Illumina

Illumina, Inc., proudly headquartered in San Diego, California, is a highly dominant, globally transformative company that single-handedly revolutionized the entire field of genomics. Founded in 1998, Illumina is the absolute, undisputed global leader in Next-Generation Sequencing (NGS) and advanced microarray technologies. Operating as a colossal enterprise with approximately 8,600 employees and generating $4.3 billion in revenue for fiscal year 2025, the company provides the absolute foundational tools required to effortlessly read the fundamental code of life.

The company’s highly complex, proprietary sequencing-by-synthesis (SBS) chemistry fundamentally drove the cost of sequencing a complete human genome down from hundreds of millions of dollars to just a couple hundred dollars today. This absolutely staggering technological leap has effectively democratized massive genomic research, completely enabling the modern era of precision medicine, advanced oncology diagnostics, and complex non-invasive prenatal testing (NIPT).

Illumina’s highly robust portfolio of sequencers scales to meet any operational demand. It ranges from small, rapid benchtop units like the MiSeq—used in small hospital labs for targeted infectious disease tracing—to massive, ultra-high-throughput production-scale machines like the NovaSeq X Plus. This flagship system is an absolute powerhouse capable of generating up to 16 terabases (Tb) of output, or up to 52 billion single reads, per dual flow cell run. Such colossal throughput is heavily utilized by massive national genome projects and pharma R&D centers to sequence tens of thousands of genomes annually.

To manage the staggering volumes of data generated by these machines, the company heavily invests in highly advanced bioinformatics software, most notably the DRAGEN Bio-IT platform, to help researchers rapidly and accurately decipher massive genomic datasets. By providing the essential infrastructure for global genomics, Illumina stands as one of the most profoundly impactful technological companies in modern human history.